Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on June 3, 2025
Good-Lite Company. Now a preferred supplier for U.S. Veterans Association through GSA Schedule
EIN Presswire
·
June 3, 2025
Good-Lite Company is proud to announce its inclusion on the United States Veterans Association's list of preferred suppliers. ELGIN, IL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Good-Lite Company., a leader in visual acuity screening solutions, …
Dr. Sam Speron Shares Advances in Plastic and Reconstructive Surgery
EIN Presswire
·
June 3, 2025
Dr. Sam Speron Shares Advances in Plastic and Reconstructive Surgery CHICAGO, IL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- As younger adults increasingly seek preventative measures against aging, a subtle and strategic form of Botox—known as “ …
Altis Labs Announces Presentation of Results at ASCO 2025: IPRO-Δ Outperforms RECIST in Predicting OS in Ph 3 Trial
EIN Presswire
·
June 3, 2025
CHICAGO, IL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Altis Labs, Inc. (“Altis”), the computational imaging company accelerating clinical trials with AI, announces the presentation of findings at the American Society of Clinical Oncology (ASCO) …
Local Couple Brings Heart-Centered Home Care to Vernon Hills Families
EIN Presswire
·
June 3, 2025
Billy and Jamie Huh Open Crescent Home Care After Personal Journey Reveals Need for Authentic, Compassionate Care VERNON HILLS, IL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Sometimes life has a way of showing us exactly where we're meant to be. …
Calcium LLC Expands Sales Team with Strategic New Hires
EIN Presswire
·
June 3, 2025
James Emmert, Courtney Shaffer, and Saaj Singh join to fuel growth and broaden reach across provider and enterprise markets. CHICAGO, IL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Calcium LLC, a leader in digital health solutions and patient …
Barrington Orthopedic Specialists Improves Pain and Mobility with the Prescribe FIT Conservative Treatment
EIN Presswire
·
June 3, 2025
BARRINGTON, IL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Barrington Orthopedic Specialists, a premier provider of advanced orthopedic care in the northwest suburbs of Chicago, is transforming patient outcomes through the Prescribe FIT program. …
Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
GlobeNewswire
·
June 3, 2025
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the pricing and early acceptance results of its previously announced tender offers (the “Offers”) to purchase for cash …
Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program
GlobeNewswire
·
June 3, 2025
Recently disclosed clinical cohort data from high (1x1015 total vg) and low dose (5.7x1014 total vg) TSHA-102 from REVEAL adolescent/adult and pediatric Phase 1/2 trials Caregiver research regarding gain/regain of developmental milestones supporting …
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today …
Fennec Announces Results of Annual Meeting
GlobeNewswire
·
June 3, 2025
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 25, 2025 were elected as directors of …
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
GlobeNewswire
·
June 3, 2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June 1, 2025, in connection with commencing employment, two …
DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
GlobeNewswire
·
June 3, 2025
Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en …
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
GlobeNewswire
·
June 3, 2025
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …
Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
GlobeNewswire
·
June 3, 2025
ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30 Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
GlobeNewswire
·
June 3, 2025
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee …
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
GlobeNewswire
·
June 3, 2025
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 3, 2025
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 3, 2025
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
GlobeNewswire
·
June 3, 2025
ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
GlobeNewswire
·
June 3, 2025
KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has received …